Prospects of improving biological therapy effectiveness for rhinosinusitis with nasal polyps

Nosulya E.V.; Kim I.A.

doi:https://doi.org/10.17116/rosrino20253304144

Nosulya E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0002-3897-8384

Kim I.A.

National Medical Research Center of Otorhinolaryngology

ORCID: 0000-0003-1078-6388

Prospects of improving biological therapy effectiveness for rhinosinusitis with nasal polyps

Authors:

Nosulya E.V., Kim I.A.

More about the authors

Journal: Russian Rhinology. 2025;33(4): 44‑48

DOI: 10.17116/rosrino20253304144

Read: 447 times

Contact the author

Table of contents

To cite this article:

Nosulya EV, Kim IA. Prospects of improving biological therapy effectiveness for rhinosinusitis with nasal polyps. Russian Rhinology. 2025;33(4):44‑48. (In Russ.)
https://doi.org/10.17116/rosrino20253304144

Подписка 2026 Российская ринология (Russian Rhinology)

Использование инфографики авторами научных работ

Recommended articles:

Sinonasal pathology in patients with primary ciliary dyskinesia. Russian Rhinology. 2025;(3):223-232

Clinical efficacy of dupilumab monoclonal antibody in the treatment of recurrent severe chronic rhinosinusitis with nasal polyps without bronchial asthma. Russian Rhinology. 2025;(4):32-37

Synergistic efficiency of preformed physical factors and dupilumab in the treatment of polypous rhinosinusitis. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2025;(2):16-23

Relationship between oxidative stress patterns and proinflammatory cytokines in patients with polypous rhinosinusitis under the course of therapeutic physical factors. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2025;(2):42-49

Monoclonal antibodies in the treatment of recurrent polyposis rhinosinusitis. Literature review. Russian Bulletin of Otorhinolaryngology. 2025;(4):96-104

Psychodermatological aspects of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Venereology. 2025;(4):403-411

Mechanisms of additivity of physiotherapeutic factors in complex therapy of polypous rhinosinusitis complicated by comorbidities. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2025;(3):5-11

Clinical discussion of patients with follicular occlusion syndrome and comorbid pathology. Russian Journal of Clinical Dermatology and Venereology. 2025;(5):596-603

Development of a predictive model for the identification of patients with high risk of psoriatic arthritis and assessment of the efficacy of early treatment with netakimab, IL-17A inhibitor. Russian Journal of Clinical Dermatology and Venereology. 2025;(5):625-634

Abstract:

Improving the effectiveness of rhinosinusitis with nasal polyps (RSwNP) treatment is currently associated with application of biological therapy aimed at affecting certain molecular targets responsible for development and maintenance of inflammation. Thymic stromal lymphopoietin (TSLP) is one of such potential targets. Blocking of TSLP may be more effective in fight against respiratory tract inflammation than existing biological drugs. This is due to the fact that TSLP is at the outset of inflammatory response mediating a wide range of subsequent processes that include the development of both eosinophilic and neutrophilic inflammation, as well as structural changes in the respiratory tract. The article presents the overview of results of tezepelumab clinical use in RSwNP, in presence of which a significant decrease in polyps’ size and nasal stuffiness, improvement of the olfaction and life quality, as well as a significant reduction in the necessity of surgical treatment and systemic glucocorticoids have been shown.

Keywords:

rhinosinusitis with nasal polyps

biological therapy

thymic stromal lymphopoietin

tezepelumab

Authors:

Nosulya E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0002-3897-8384

Kim I.A.

National Medical Research Center of Otorhinolaryngology

ORCID: 0000-0003-1078-6388

Received:

04.11.2025

Accepted:

17.11.2025

Close metadata

References:

Fokkens WJ, Viskens AS, Backer V, Conti D, De Corso E, Gevaert P, Scadding GK, Wagemann M, Bernal-Sprekelsen M, Chaker A, Heffler E, Han JK, Van Staeyen E, Hopkins C, Mullol J, Peters A, Reitsma S, Senior BA, Hellings PW.EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. Rhinology. 2023;61(3):194-202. https://doi.org/10.4193/Rhin22.489
Ryazancev SV. Mnogofaktornaya teoriya etiologii i patogeneza polipoza nosa i okolonosovyh pazuh. Aktual’naya otorinolaringologiya. 2002;3(16-23):336. (In Russ.).
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, Wang de Y, Wormald PJ. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012 Mar;23:3 p preceding table of contents, 1-298.
Stevens WW, Schleimer RP, Kern RC. Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):565-572. https://doi.org/10.1016/j.jaip.2016.04.012
Larsen PL, Nos M. Origin of nasal polyps: an endoscopic autopsy study. Laryngoscope. 2004 Apr;114(4):710-719. https://doi.org/10.1097/00005537-200404000-00022
Nosulya EV, Kim IA, Afanas’eva NV, Sumbaeva OV. Rasprostranennost’ polipoznogo rinosinusita sredi gorodskogo naseleniya Vostochnoj Sibiri. Russian Rhinology. 2007;1:4-7. (In Russ.).
Kim IA, Nosulya EV, Ryazancev SV, Egorov VI, Karpishchenko SA, Karneeva OV, Svistushkin VM, Abdulkerimov HT, Averbuh VM, Tkachuk IV; Nacional’naya medicinskaya associaciya otorinolaringologov. Polipoznyj rinosinusit. Klinicheskie rekomendacii (odobreny Minzdravom Rossii); 2024. (In Russ.).
Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, Toppila-Salmi S, Bernal-Sprekelsen M, Mullol J, Alobid I, Terezinha Anselmo-Lima W, Bachert C, Baroody F, von Buchwald C, Cervin A, Cohen N, Constantinidis J, De Gabory L, Desrosiers M, Diamant Z, Douglas RG, Gevaert PH, Hafner A, Harvey RJ, Joos GF, Kalogjera L, Knill A, Kocks JH, Landis BN, Limpens J, Lebeer S, Lourenco O, Meco C, Matricardi PM, O’Mahony L, Philpott CM, Ryan D, Schlosser R, Senior B, Smith TL, Teeling T, Tomazic PV, Wang DY, Wang D, Zhang L, Agius AM, Ahlstrom-Emanuelsson C, Alabri R, Albu S, Alhabash S, Aleksic A, Aloulah M, Al-Qudah M, Alsaleh S, Baban MA, Baudoin T, Balvers T, Battaglia P, Bedoya JD, Beule A, Bofares KM, Braverman I, Brozek-Madry E, Richard B, Callejas C, Carrie S, Caulley L, Chussi D, de Corso E, Coste A, El Hadi U, Elfarouk A, Eloy PH, Farrokhi S, Felisati G, Ferrari MD, Fishchuk R, Grayson W, Goncalves PM, Grdinic B, Grgic V, Hamizan AW, Heinichen JV, Husain S, Ping TI, Ivaska J, Jakimovska F, Jovancevic L, Kakande E, Kamel R, Karpischenko S, Kariyawasam HH, Kawauchi H, Kjeldsen A, Klimek L, Krzeski A, Kopacheva Barsova G, Kim SW, Lal D, Letort JJ, Lopatin A, Mahdjoubi A, Mesbahi A, Netkovski J, Nyenbue Tshipukane D, Obando-Valverde A, Okano M, Onerci M, Ong YK, Orlandi R, Otori N, Ouennoughy K, Ozkan M, Peric A, Plzak J, Prokopakis E, Prepageran N, Psaltis A, Pugin B, Raftopulos M, Rombaux P, Riechelmann H, Sahtout S, Sarafoleanu CC, Searyoh K, Rhee CS, Shi J, Shkoukani M, Shukuryan AK, Sicak M, Smyth D, Sindvongs K, Soklic Kosak T, Stjarne P, Sutikno B, Steinsvag S, Tantilipikorn P, Thanaviratananich S, Tran T, Urbancic J, Valiulius A, Vasquez de Aparicio C, Vicheva D, Virkkula PM, Vicente G, Voegels R, Wagenmann MM, Wardani RS, Welge-Lussen A, Witterick I, Wright E, Zabolotniy D, Zsolt B, Zwetsloot CP. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020 Feb;58(Suppl S29):1-464. https://doi.org/10.4193/Rhin20.600
Yung MW, Gould J, Upton GJ. Nasal polyposis in children with cystic fibrosis: a long-term follow-up study. Ann Otol Rhinol Laryngol. 2002 Dec; 111(12 Pt 1):1081-1086. https://doi.org/10.1177/000348940211101204
Belvisi MG. Regulation of inflammatory cell function by corticosteroids. Proc Am Thorac Soc. 2004;1(3):207-214. https://doi.org/10.1513/pats.200402-002MS
Kim IA, Ragimova DR, Nosulya EV, Pervichko EI, Grishanina AM. Priverzhennost’ lecheniyu pacientov s nazal’noj obstrukciej. Russian Rhinology. 2020;28(3):164-166. (In Russ.). https://doi.org/10.17116/rosrino202028031164
Thomas WW 3rd, Harvey RJ, Rudmik L, Hwang PH, Schlosser RJ. Distribution of topical agents to the paranasal sinuses: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2013 Sep;3(9):691-703. https://doi.org/10.1002/alr.21172
Poetker DM, Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol Clin North Am. 2010 Aug;43(4):753-768. https://doi.org/10.1016/j.otc.2010.04.003
Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001 Apr;107(4):607-614. https://doi.org/10.1067/mai.2001.112374
Shi LL, Xiong P, Zhang L, Cao PP, Liao B, Lu X, Cui YH, Liu Z. Features of airway remodeling in different types of Chinese chronic rhinosinusitis are associated with inflammation patterns. Allergy. 2013 Jan;68(1):101-109. https://doi.org/10.1111/all.12064
Kimura S, Pawankar R, Mori S, Nonaka M, Masuno S, Yagi T, Okubo K. Increased expression and role of thymic stromal lymphopoietin in nasal polyposis. Allergy Asthma Immunol Res. 2011 Jul;3(3):186-193. https://doi.org/10.4168/aair.2011.3.3.186
Nagarkar DR, Poposki JA, Tan BK, Comeau MR, Peters AT, Hulse KE, Suh LA, Norton J, Harris KE, Grammer LC, Chandra RK, Conley DB, Kern RC, Schleimer RP, Kato A. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2013 Sep;132(3):593-600.e12. https://doi.org/10.1016/j.jaci.2013.04.005
Menzies-Gow A, Wechsler ME, Brightling CE. Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option? Respir Res. 2020 Oct 15;21(1):268. https://doi.org/10.1186/s12931-020-01505-x
Jacobs JS, Han JK, Lee JK, Laidlaw TM, Martin NL, Caveney S, Ambrose CS, Martin N, Spahn JD, Hoyte FCL. Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps. Adv Ther. 2025 Jan;42(1):510-522. https://doi.org/10.1007/s12325-024-03006-5
Lipworth BJ, Han JK, Desrosiers M, Hopkins C, Lee SE, Mullol J, Pfaar O, Li T, Chen C, Almqvist G, Margolis MK, McLaren J, Jagadeesh S, MacKay J, Megally A, Hellqvist Å, Mankad VS, Bahadori L, Ponnarambil SS; WAYPOINT Study Investigators. Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps. N Engl J Med. 2025 Mar 27; 392(12): 1178-1188. https://doi.org/10.1056/NEJMoa241448220